The contest closes June 30, 2013
MONTREAL, May 29, 2013 /CNW Telbec/ - Canadians across the country are
invited to participate in the Shire BRAVE Awards, an international program intended to recognize the courage and
dedication of non-professional caregivers. The initiative will lead to
the selection of up to 20 nominees from around the world - everyday
heroes who provide regular, consistent care to another person without
receiving formal compensation for their deeds. The winners will each
receive the equivalent of a $10,000 USD monetary award. Canadians are
invited to submit the nomination of a caregiver they believe deserves
recognition by completing the online form through the official website
at www.ShireBRAVEawards.com. Nominations for the 2013 Shire BRAVE Awards are being accepted until
June 30, 2013. Award recipients will be announced in November 2013.
About the Shire BRAVE Awards
The Shire BRAVE Awards is an international program created by Shire to
honor the courage and dedication of individual voluntary caregivers.
For the Shire BRAVE Awards, a caregiver is defined as an individual who
is providing regular, consistent care for another person(s). The
caregiver cannot be a professional healthcare provider and cannot be
compensated in any formal way through their efforts as a caregiver.
The caregiver can be a relative, neighbor, or friend who gives their
time, support, and compassion regularly, helping another person(s) who
is (partly or wholly) unable to care for themselves due to health and
wellness issues, injury, or other extenuating circumstance.
Nominations for the 2013 BRAVE Awards will be accepted through June 30,
2013 and award recipients will be announced in November 2013. For
further information on the Shire BRAVE Awards, including official
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative
specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing
treatments for symptomatic conditions treated by specialist physicians
in other targeted therapeutic areas.
SOURCE: Shire Canada Inc.
For further information:
Brigitte Viel (firstname.lastname@example.org) 514-787-5114
Matthew Cabrey (email@example.com) 1-484-595 8248